1q01: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(12 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
== | ==Lebetin peptides, a new class of potent aggregation inhibitors== | ||
<StructureSection load='1q01' size='340' side='right'caption='[[1q01]]' scene=''> | |||
[[Category: | == Structural highlights == | ||
[[Category: | <table><tr><td colspan='2'>[[1q01]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Macrovipera_lebetinus Macrovipera lebetinus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Q01 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1Q01 FirstGlance]. <br> | ||
[[Category: | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 24 models</td></tr> | ||
[[Category: | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1q01 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1q01 OCA], [https://pdbe.org/1q01 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1q01 RCSB], [https://www.ebi.ac.uk/pdbsum/1q01 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1q01 ProSAT]</span></td></tr> | ||
[[Category: Ganzalez | </table> | ||
[[Category: Giralt | == Function == | ||
[[Category: Mabrouk | [https://www.uniprot.org/uniprot/LEB_MACLB LEB_MACLB] Lebetins inhibit platelet aggregation induced by thrombin, collagen and PAF-acether. Human platelet aggregation induced by thrombin is inhibited by synthetic lebetin-1-alpha, lebetin-1-beta, lebetin-1-gamma, lebetin-2-alpha and lebetin-2-beta with IC(50) values of 140, 32, 5, 2.5 and 2.8 nM, respectively. Lebetins also inhibit fibrinogen-induced aggregation of alpha-chymotrypsin-treated platelets as well as in vivo collagen-induced thrombocytopenia in rats. Lebetins are not toxic upon intravenous injection into mice and rats.<ref>PMID:11910186</ref> <ref>PMID:8769304</ref> <ref>PMID:9839678</ref> | ||
[[Category: Marrakchi | == References == | ||
[[Category: Mosbah | <references/> | ||
__TOC__ | |||
[[Category: Rochat | </StructureSection> | ||
[[Category: Sabatier | [[Category: Large Structures]] | ||
[[Category: | [[Category: Macrovipera lebetinus]] | ||
[[Category: Darbon H]] | |||
[[Category: El Ayeb M]] | |||
[[Category: Ganzalez MJ]] | |||
[[Category: Giralt E]] | |||
[[Category: Mabrouk K]] | |||
[[Category: Marrakchi N]] | |||
[[Category: Mosbah A]] | |||
[[Category: Rochat H]] | |||
[[Category: Sabatier JM]] | |||
[[Category: Van Rietschoten J]] |
Latest revision as of 10:14, 30 October 2024
Lebetin peptides, a new class of potent aggregation inhibitorsLebetin peptides, a new class of potent aggregation inhibitors
Structural highlights
FunctionLEB_MACLB Lebetins inhibit platelet aggregation induced by thrombin, collagen and PAF-acether. Human platelet aggregation induced by thrombin is inhibited by synthetic lebetin-1-alpha, lebetin-1-beta, lebetin-1-gamma, lebetin-2-alpha and lebetin-2-beta with IC(50) values of 140, 32, 5, 2.5 and 2.8 nM, respectively. Lebetins also inhibit fibrinogen-induced aggregation of alpha-chymotrypsin-treated platelets as well as in vivo collagen-induced thrombocytopenia in rats. Lebetins are not toxic upon intravenous injection into mice and rats.[1] [2] [3] References
|
|